Translational Oncology
- Biomarker discovery
- Mouse clinical trial
- 61 PDX-derived primary cancer cell lines
- Drug-resistant xenograft models
- Combination therapy platform including radiation
- World leading genome sequencing and bioinformatics capability
translational Oncology 20200513
Related Content
High-dimensional (HD) flow cytometry allows researchers to perform deep phenotyping of immune cells at the single cell level with increased...
VIEW RESOURCEWe offer an extensive panel of cutting-edge immune profiling and biomarker discovery services to support: Target discovery and validation Drug...
VIEW RESOURCE